Eli Lilly announced it is buying AtaiBeckley in a bet on neuroscience and psychiatric pharmaceuticals.
What happened: AtaiBeckley (ATAI) stock jumped 30% pre-market Thursday after Eli Lilly (LLY) said it would acquire the clinical-stage biopharmaceutical company.
What's behind the move: Eli Lilly is … [+1400 chars]
What's behind the move: Eli Lilly is … [+1400 chars]